Association of Age at Onset and First Symptoms With Disease Progression in Patients With Metachromatic Leukodystrophy

  • Christiane Kehrer
    From Department of Paediatric Neurology and Developmental Medicine (C.K., S.E., C.R., J.B., A.B., N.K., I.K.-M., S.G.), University Children's Hospital; Department of Medical Genetics (S.B.-W.), University Hospital Tübingen; Clinical Neurogenetics Section (L.S.), Department of Neurology and Hertie Institute for Clinical Brain Research, University of Tübingen; and German Center for Neurodegenerative Diseases (DZNE) Tübingen (L.S.), Germany Crona Kliniken.
  • Saskia Elgün
    From Department of Paediatric Neurology and Developmental Medicine (C.K., S.E., C.R., J.B., A.B., N.K., I.K.-M., S.G.), University Children's Hospital; Department of Medical Genetics (S.B.-W.), University Hospital Tübingen; Clinical Neurogenetics Section (L.S.), Department of Neurology and Hertie Institute for Clinical Brain Research, University of Tübingen; and German Center for Neurodegenerative Diseases (DZNE) Tübingen (L.S.), Germany Crona Kliniken.
  • Christa Raabe
    From Department of Paediatric Neurology and Developmental Medicine (C.K., S.E., C.R., J.B., A.B., N.K., I.K.-M., S.G.), University Children's Hospital; Department of Medical Genetics (S.B.-W.), University Hospital Tübingen; Clinical Neurogenetics Section (L.S.), Department of Neurology and Hertie Institute for Clinical Brain Research, University of Tübingen; and German Center for Neurodegenerative Diseases (DZNE) Tübingen (L.S.), Germany Crona Kliniken.
  • Judith Böhringer
    From Department of Paediatric Neurology and Developmental Medicine (C.K., S.E., C.R., J.B., A.B., N.K., I.K.-M., S.G.), University Children's Hospital; Department of Medical Genetics (S.B.-W.), University Hospital Tübingen; Clinical Neurogenetics Section (L.S.), Department of Neurology and Hertie Institute for Clinical Brain Research, University of Tübingen; and German Center for Neurodegenerative Diseases (DZNE) Tübingen (L.S.), Germany Crona Kliniken.
  • Stefanie Beck-Wödl
    From Department of Paediatric Neurology and Developmental Medicine (C.K., S.E., C.R., J.B., A.B., N.K., I.K.-M., S.G.), University Children's Hospital; Department of Medical Genetics (S.B.-W.), University Hospital Tübingen; Clinical Neurogenetics Section (L.S.), Department of Neurology and Hertie Institute for Clinical Brain Research, University of Tübingen; and German Center for Neurodegenerative Diseases (DZNE) Tübingen (L.S.), Germany Crona Kliniken.
  • Andrea Bevot
    From Department of Paediatric Neurology and Developmental Medicine (C.K., S.E., C.R., J.B., A.B., N.K., I.K.-M., S.G.), University Children's Hospital; Department of Medical Genetics (S.B.-W.), University Hospital Tübingen; Clinical Neurogenetics Section (L.S.), Department of Neurology and Hertie Institute for Clinical Brain Research, University of Tübingen; and German Center for Neurodegenerative Diseases (DZNE) Tübingen (L.S.), Germany Crona Kliniken.
  • Nadja Kaiser
    From Department of Paediatric Neurology and Developmental Medicine (C.K., S.E., C.R., J.B., A.B., N.K., I.K.-M., S.G.), University Children's Hospital; Department of Medical Genetics (S.B.-W.), University Hospital Tübingen; Clinical Neurogenetics Section (L.S.), Department of Neurology and Hertie Institute for Clinical Brain Research, University of Tübingen; and German Center for Neurodegenerative Diseases (DZNE) Tübingen (L.S.), Germany Crona Kliniken.
  • Ludger Schöls
    From Department of Paediatric Neurology and Developmental Medicine (C.K., S.E., C.R., J.B., A.B., N.K., I.K.-M., S.G.), University Children's Hospital; Department of Medical Genetics (S.B.-W.), University Hospital Tübingen; Clinical Neurogenetics Section (L.S.), Department of Neurology and Hertie Institute for Clinical Brain Research, University of Tübingen; and German Center for Neurodegenerative Diseases (DZNE) Tübingen (L.S.), Germany Crona Kliniken.
  • Ingeborg Krägeloh-Mann
    From Department of Paediatric Neurology and Developmental Medicine (C.K., S.E., C.R., J.B., A.B., N.K., I.K.-M., S.G.), University Children's Hospital; Department of Medical Genetics (S.B.-W.), University Hospital Tübingen; Clinical Neurogenetics Section (L.S.), Department of Neurology and Hertie Institute for Clinical Brain Research, University of Tübingen; and German Center for Neurodegenerative Diseases (DZNE) Tübingen (L.S.), Germany Crona Kliniken.
  • Samuel Groeschel
    From Department of Paediatric Neurology and Developmental Medicine (C.K., S.E., C.R., J.B., A.B., N.K., I.K.-M., S.G.), University Children's Hospital; Department of Medical Genetics (S.B.-W.), University Hospital Tübingen; Clinical Neurogenetics Section (L.S.), Department of Neurology and Hertie Institute for Clinical Brain Research, University of Tübingen; and German Center for Neurodegenerative Diseases (DZNE) Tübingen (L.S.), Germany Crona Kliniken.

収録刊行物

  • Neurology

    Neurology 96 (2), e255-, 2021-01-12

    Ovid Technologies (Wolters Kluwer Health)

被引用文献 (1)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ